Antony Accordino B Pharm, MPS, MBA is the Director of Oxford Compounding. He was the first member of the Professional Compounding Chemists of America (PCCA) in Western Australia as well as having the first compounding-only pharmacy. His background is one of extensive hospital experience at Princess Margaret Hospital for Children (PMH) the pediatric teaching hospital in Western Australia.
During his time at PMH he was one of a team that enabled institution obtain a licence from the Therapeutic Goods Administration (TGA) to manufacture pharmaceuticals, this was a unique achievement for a hospital pharmacy.
Pain management is the medical specialty born out of the need for treating all types of pain, including musculoskeletal, spinal and neuropathic pain disorders. With an accurate diagnosis and early intervention, we hope to help patients avoid spiraling into a state of chronic pain, or at least reduce the severity of pain, and improve patients’ quality of life. Minimally invasive procedures and proper use of medications are implemented to achieve those goals.
The treatment of pain is guided by the history of the pain, its intensity, duration, aggravating and relieving conditions, and structures involved in causing the pain. In order for a structure to cause pain, it must have a nerve supply, be susceptible to injury, and stimulation of the structure should cause pain. The concept behind most interventional procedures for treating pain is that there is a specific structure in the body with nerves of sensation that is generating the pain. Pain management has a role in identifying the precise source of the problem and isolating the optimal treatment.
Fluoroscopy is an X-ray guided viewing method. Fluoroscopy is often used to assist the doctor in precisely locating the injection so that the medication reaches the appropriate spot and only the appropriate spot.
Our focus is providing the best possible treatments available to patients